LAS VEGAS – After 3-6 months of remission induction therapy with high-dose steroids and cyclophosphamide, it’s time to switch ANCA-associated vasculitis patients to maintenance therapy.
Recent studies have shown it’s not necessary to go beyond that point with induction treatment; patients do well by then with less toxic maintenance agents.
Dr. Brian Mandell explained how he and his colleagues at the Cleveland Clinic handle the matter and what they use for maintenance therapy, at the conference held by Global Academy for Medical Education. Global Academy for Medical Education and this news organization are owned by Frontline Medical Communications.